Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome

By |2018-01-22T15:17:21+00:00October 15th, 2017|Categories: DSF Research Review|Tags: , |

(Kaplan, et al. 2017) Parents often report "improved behavior" or "improved cognition" when they initiate cannabidiol (CBD) treatment in their children with Dravet syndrome, with and without improved seizure control. This project sought to measure the effect of CBD on seizure control, autistic-like behaviors, and specific neuron action. They found that when mice were given [...]

Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome

By |2017-07-09T15:56:26+00:00July 9th, 2017|Categories: DSF Research Review|Tags: , |

(Devinsky, et al. 2017) The long-anticipated results from the first randomized, double blind, placebo controlled trial of cannabidiol (CBD) in Dravet syndrome show that cannabidiol can help alleviate seizures in this syndrome. While there have been anecdotal stories of success with CBD in Dravet syndrome since as early as 2012, this trial represents the first [...]